Althea Pharma Private Limited
Indian Pharmaceutical Exporter ยท Respiratory Specialist ยท $2.4M Total Trade ยท DGFT Verified
Althea Pharma Private Limited is an Indian pharmaceutical exporter with a total trade value of $2.4M across 3 products in 1 therapeutic categories. Based on 602 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Salbutamol ($1.2M), Ipratropium ($685.5K), Budesonide ($578.6K).
Althea Pharma Private Limited โ Export Portfolio & Destination Treemap

Who is Althea Pharma Private Limited? โ Company Overview & Market Position
Althea Pharma Private Limited, established on May 27, 2004, is a privately held pharmaceutical company headquartered in Vapi, Gujarat, India. The company is registered under the Corporate Identification Number (CIN) U24232GJ2004PTC044200. As of the latest available data, Althea Pharma has an authorized capital of โน5.00 crore and a paid-up capital of โน68.78 lakh. The company is unlisted and operates as a non-government entity. Its registered office is located at Room No. 403, Al-Husan Place, Godal Nagar, Vapi, Gujarat, 396191, India.
Althea Pharma specializes in the manufacturing of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company's product portfolio is concentrated in the respiratory therapeutic category, with a focus on inhalants such as Salbutamol, Ipratropium, and Budesonide. In the fiscal year 2022, Althea Pharma reported a total export value of $2.4 million USD, comprising 602 shipments. The top three exported products were Salbutamol ($1.2 million, 0.8% market share), Ipratropium ($686,000, 1.2% market share), and Budesonide ($579,000, 0.3% market share). Notably, the company's portfolio is highly concentrated, with the top five products accounting for 100% of its exports.